## **Core Concept**
Rituximab is a monoclonal antibody that targets the CD20 antigen found on the surface of B cells, leading to their depletion. It is used in the treatment of various conditions, including certain types of lymphoma, leukemia, rheumatoid arthritis, and others. The use of rituximab can be associated with several side effects, but one of its dreaded complications is related to its immunosuppressive effects.

## **Why the Correct Answer is Right**
The correct answer, , refers to **Tumor Lysis Syndrome (TLS)**. TLS is a potentially life-threatening complication that can occur after the initiation of rituximab, especially in patients with high tumor burden. As rituximab causes rapid destruction of cancer cells, it can lead to the release of large amounts of intracellular contents, including potassium, phosphate, and nucleic acids, into the bloodstream. This can result in hyperkalemia, hyperphosphatemia, hypocalcemia, and acute kidney injury.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While infusion reactions can occur with rituximab, they are not typically considered the "dreaded" complication. Infusion reactions are common but usually manageable with premedication and adjustment of infusion rates.
- **Option B:** Although rituximab increases the risk of infections due to its immunosuppressive effects, the term "" is not specific enough to be considered the dreaded complication directly associated with rituximab.
- **Option C:** This option is not provided, but based on the structure, it seems we are focusing on .
- **Option D:** Without a specific option provided for D, we focus on the fact that TLS is a critical and immediate concern.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **Tumor Lysis Syndrome (TLS) is a medical emergency** that requires prompt recognition and treatment. Prophylactic measures, including hydration, allopurinol, and rasburicase, are often used to prevent TLS in high-risk patients. Early identification of patients at risk and close monitoring of laboratory values post-treatment are crucial.

## **Correct Answer:** . Tumor Lysis Syndrome